EVICTION Study: ICT01, an Anti-Butyrophilin 3A Monoclonal Antibody Activating Γ9δ2 T Cells in Combination with Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma.Stephane Champiat,Martin Wermke,Cecile Vicier, Johann S. De Bono,Emiliano Calvo, Jorge Ramon, Evan Thomas Hall,Elena Garralda,Vladimir Galvao,Emanuela Romano,Antoine Italiano,Esma Saada, Benoit You,Aude De Gassart, Maelle Mairesse,Emmanuel Valentin,Patrick Brune,Daniel Olive, Katrien Lemmens,Paul FrohnaJOURNAL OF CLINICAL ONCOLOGY（2024）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
